First Commonwealth Financial Corp Pfizer Inc Transaction History

First Commonwealth Financial Corp

$374 Million
Q2 2024

A detailed history of First Commonwealth Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, First Commonwealth Financial Corp holds 7,445 shares of PFE stock, worth $213,001. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,445

Previous 7,908 5.85%

Holding current value

$213,001

Previous $219,000 5.02%

% of portfolio

0.06%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $11,695 - $13,704	-463 Reduced 5.85%	7,445 $208,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $5,669 - $6,510	-219 Reduced 2.69%	7,908 $219,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $29,553 - $38,386	-1,131 Reduced 12.22%	8,127 $233,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $15,659 - $18,304	488 Added 5.56%	9,258 $307,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $1,083 - $1,253	-30 Reduced 0.34%	8,770 $321,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $1,969 - $2,564	-50 Reduced 0.56%	8,800 $359,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $8,558 - $11,172	-205 Reduced 2.26%	8,850 $453,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $8,970 - $10,951	205 Added 2.32%	9,055 $396,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $95,712 - $113,484	-2,057 Reduced 18.86%	8,850 $464,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $95,480 - $118,312	2,087 Added 23.66%	10,907 $564,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $123 - $183	-3 Reduced 0.03%	8,820 $521,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $3,375 - $4,336	-86 Reduced 0.97%	8,823 $379,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $22,084 - $25,018	615 Added 7.41%	8,909 $349,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $1,507 - $1,699	-45 Reduced 0.54%	8,294 $301,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $5,020 - $6,384	150 Added 1.83%	8,339 $307,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $44,450 - $52,150	1,400 Added 20.62%	8,189 $301,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $11,837 - $14,360	-393 Reduced 5.47%	6,789 $222,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $14,295 - $18,537	-440 Reduced 5.77%	7,182 $258,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $13,127 - $14,739	-355 Reduced 4.45%	7,622 $330,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $91,987 - $101,063	-2,453 Reduced 23.52%	7,977 $338,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $11,541 - $13,158	300 Added 2.96%	10,430 $455,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $24,439 - $29,643	-709 Reduced 6.54%	10,130 $447,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $13,587 - $14,485	412 Added 3.95%	10,839 $393,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $27,251 - $31,615	-854 Reduced 7.57%	10,427 $370,000
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $13,869 - $14,715	417 Added 3.84%	11,281 $408,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $14,260 - $15,709	460 Added 4.42%	10,864 $388,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,404	10,404 $350,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.

Account

First Commonwealth Financial Corp Pfizer Inc Transaction History